The Impact of SARS-CoV-2 on Inflammatory Bowel Disease

被引：5
|
作者：
Estevinho, Maria Manuela [1 ,2 ]
Magro, Fernando [1 ,3 ,4 ,5 ]
机构：
[1] Univ Porto, Dept Biomed, Unit Pharmacol & Therapeut, Fac Med, Porto, Portugal
[2] Ctr Hosp Vila Nova de Gaia Espinho, Dept Gastroenterol, Vila Nova De Gaia, Portugal
[3] Ctr Hosp Sao Joao, Dept Gastroenterol, Alameda Prof Hernani Monteiro, PT-4200319 Porto, Portugal
[4] Ctr Drug Discovery & Innovat Med, MedInUP, Porto, Portugal
[5] Ctr Hosp Univ Sao Joao, Unidade Farmacol Clin, Porto, Portugal
来源：
GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY | 2020年 / 27卷 / 04期
关键词：
COVID-19; Crohn's disease; Ulcerative colitis; SARS-CoV-2;
D O I：
10.1159/000508114
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：227 / 229
页数：3
相关论文
共 50 条
  • [1] SARS-CoV-2 vaccination for patients with inflammatory bowel disease
    Garrido, Hannah M. Garcia
    Grobusch, Martin P.
    D'Haens, Geert R. A. M.
    Goorhuis, Abraham
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : S23 - S23
  • [2] Incidence of SARS-CoV-2 infection in inflammatory bowel disease
    Lee, M. H.
    Ng, C. H.
    Chin, Y. H.
    Muthiah, M.
    Foo, F. J.
    Chong, C. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (11) : 2021 - 2022
  • [3] SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
    Garcia Mateo, S.
    Martinez-Dominguez, S. J.
    Aso Gonzalvo, M. C.
    Gargallo-Puyuelo, C. J.
    Gallego Llera, B.
    Arroyo Villarino, M. T.
    Laredo de la Torre, V.
    Nocito Colon, M. M. L.
    Lario Quilez, L.
    Refaie, E.
    Latre Santos, M.
    Gomollon Garcia, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S564 - S564
  • [4] Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
    Margalida Calafat
    Carlos González-Muñoza
    Marta Fortuny
    Cristina Roig
    Anna Calm
    Antonio Mombiela
    Fiorella Cañete
    Federico Bertoletti
    Laura González-González
    Marta Teller-Martín
    Jordi Gordillo
    Míriam Mañosa
    Esther Garcia-Planella
    Eugeni Domènech
    Aging Clinical and Experimental Research, 2021, 33 : 2355 - 2359
  • [5] Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
    Calafat, Margalida
    Gonzalez-Munoza, Carlos
    Fortuny, Marta
    Roig, Cristina
    Calm, Anna
    Mombiela, Antonio
    Canete, Fiorella
    Bertoletti, Federico
    Gonzalez-Gonzalez, Laura
    Teller-Martin, Marta
    Gordillo, Jordi
    Manosa, Miriam
    Garcia-Planella, Esther
    Domenech, Eugeni
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (08) : 2355 - 2359
  • [6] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
    K. A. Dvornikova
    E. Yu. Bystrova
    L. P. Churilov
    A. Lerner
    Molecular Biology Reports, 2021, 48 : 5745 - 5758
  • [7] Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
    Dvornikova, K. A.
    Bystrova, E. Yu.
    Churilov, L. P.
    Lerner, A.
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5745 - 5758
  • [8] Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination
    Charilaou, Paris
    Tricarico, Christopher
    Battat, Robert
    Scherl, Ellen J.
    Longman, Randy S.
    Lukin, Dana J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : E1493 - E1499
  • [9] SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : E44 - E45
  • [10] Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease
    Scucchi, L.
    Neri, B.
    Sarmati, L.
    Mossa, M.
    Sena, G.
    Massoud, R.
    Petruzziello, C.
    Musumeci, M.
    Marafini, I
    Calabrese, E.
    Lolli, E.
    Bernardini, S.
    Andreoni, M.
    Monteleone, G.
    Biancone, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2418 - 2424
12345